Skip to main content

Main menu

  • Home
  • Current issue
  • ERJ Early View
  • Past issues
  • For authors
    • Instructions for authors
    • Submit a manuscript
    • Author FAQs
    • Open access
    • COVID-19 submission information
  • Alerts
  • Podcasts
  • Subscriptions
  • ERS Publications
    • European Respiratory Journal
    • ERJ Open Research
    • European Respiratory Review
    • Breathe
    • ERS Books
    • ERS publications home

User menu

  • Log in
  • Subscribe
  • Contact Us
  • My Cart

Search

  • Advanced search
  • ERS Publications
    • European Respiratory Journal
    • ERJ Open Research
    • European Respiratory Review
    • Breathe
    • ERS Books
    • ERS publications home

Login

European Respiratory Society

Advanced Search

  • Home
  • Current issue
  • ERJ Early View
  • Past issues
  • For authors
    • Instructions for authors
    • Submit a manuscript
    • Author FAQs
    • Open access
    • COVID-19 submission information
  • Alerts
  • Podcasts
  • Subscriptions

The effect of pre-hospital anti-platelet therapy in adults with ARDS: A meta-analysis

Weizhong Jin
European Respiratory Journal 2016 48: OA3028; DOI: 10.1183/13993003.congress-2016.OA3028
Weizhong Jin
1Dep. of Pulmonary Medicine, Hangzhou First People's Hospital, Hangzhou, China
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Info & Metrics
Loading

Abstract

Introduction Anti-platelet agents have the potential to play a role in the treatment or prevention for acute respiratory distress syndrome (ARDS).

Aims and objectives We conducted a meta-analysis to assess the effect of pre-hospital anti-platelet therapy (APT) in adults with ARDS.

Methods We searched the PubMed, Web of Science, Cochrane Central Register of Controlled Trials, and Cochrane Database of Systematic Reviews. All human studies published in full text, abstract, or poster form were eligible for inclusion. We included prospectively or respectively cohort, case control trials or RCT. We included trials comparing the incidence of ARDS in patients with pre-hospital anti-platelet agents or not. The primary outcome was ARDS morbidity, while secondary outcome was ICU mortality.

Results We indentified 8 studies meeting the eligibility criteria (seven cohorts, one case control). Meta-analysis of 7 studies of 30291 patients showed that pre-hospital APT was associated with a decrease in the odds of ARDS compared with those without APT (OR 0.68, 95% CI 0.56 - 0.83, p=0.0001). Of these studies, three calculated the ICU mortality, showing a 5.58% in the pre-hospital APT users and 5.66% in the nonusers (OR 0.84, 95% CI 0.63 - 1.11, P = 0.22, I2 = 0%).

Conclusions Clinical studies reviewed here have provided some evidence that pre-hospital APT significantly reduce ARDS rate, but not mortality in critically ill patients, compared to that in APT nonusers. The findings suggested an early use of anti-platelet agents would be beneficial in critical care patients at risk of ARDS.

  • Acute respiratory failure
  • Critically ill patients
  • Intensive care
  • Copyright ©the authors 2016
Previous
Back to top
Vol 48 Issue suppl 60 Table of Contents
  • Table of Contents
  • Index by author
Email

Thank you for your interest in spreading the word on European Respiratory Society .

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
The effect of pre-hospital anti-platelet therapy in adults with ARDS: A meta-analysis
(Your Name) has sent you a message from European Respiratory Society
(Your Name) thought you would like to see the European Respiratory Society web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Alerts
Sign In to Email Alerts with your Email Address
Citation Tools
The effect of pre-hospital anti-platelet therapy in adults with ARDS: A meta-analysis
Weizhong Jin
European Respiratory Journal Sep 2016, 48 (suppl 60) OA3028; DOI: 10.1183/13993003.congress-2016.OA3028

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero

Share
The effect of pre-hospital anti-platelet therapy in adults with ARDS: A meta-analysis
Weizhong Jin
European Respiratory Journal Sep 2016, 48 (suppl 60) OA3028; DOI: 10.1183/13993003.congress-2016.OA3028
del.icio.us logo Digg logo Reddit logo Technorati logo Twitter logo CiteULike logo Connotea logo Facebook logo Google logo Mendeley logo

Jump To

  • Article
  • Info & Metrics
  • Tweet Widget
  • Facebook Like
  • Google Plus One

More in this TOC Section

  • Non-invasive ventilation in the emergency department from 2004-2015
  • The negative effect of initial high-dose methylprednisolone and tapering regimen for acute respiratory distress syndrome: A retrospective propensity matched cohort study
  • Acute respiratory failure in progressive neurological diseases: What is important for intensive care unit and long-term survival?
Show more 2.1 Acute Critical Care

Related Articles

Navigate

  • Home
  • Current issue
  • Archive

About the ERJ

  • Journal information
  • Editorial board
  • Reviewers
  • CME
  • Press
  • Permissions and reprints
  • Advertising

The European Respiratory Society

  • Society home
  • myERS
  • Privacy policy
  • Accessibility

ERS publications

  • European Respiratory Journal
  • ERJ Open Research
  • European Respiratory Review
  • Breathe
  • ERS books online
  • ERS Bookshop

Help

  • Feedback

For authors

  • Instructions for authors
  • Submit a manuscript
  • ERS author centre

For readers

  • Alerts
  • Subjects
  • Podcasts
  • RSS

Subscriptions

  • Accessing the ERS publications

Contact us

European Respiratory Society
442 Glossop Road
Sheffield S10 2PX
United Kingdom
Tel: +44 114 2672860
Email: journals@ersnet.org

ISSN

Print ISSN:  0903-1936
Online ISSN: 1399-3003

Copyright © 2021 by the European Respiratory Society